Регистры и их значение в оценке больных ишемической болезнью сердца, подвергающихся операциям реваскуляризации миокарда
https://doi.org/10.18705/1607-419X-2012-18-5-398-405
Аннотация
В статье рассматривается значение регистров для клинической практики и их отличия от рандомизированных клинических исследований. Приводятся данные об использовании регистров и баз данных для оценки больных, перенесших реваскуляризацию миокарда. Обосновывается необходимость создания регистра больных, подвергающихся плановым операциям аорто-коронарного шунтирования.
Об авторах
А. В. Панов
ФГБУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова» Минздравсоцразвития РФ
Россия
Россия
Э. В. Кулешова
ФГБУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова» Минздравсоцразвития РФ
Россия
Россия
Список литературы
1. Mehta R.H., Roe M.T., Chen A.Y. et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative // Arch. Intern. Med. — 2006. — Vol. 166, № 18. — P. 2027-2034.
2. Fox K.A., Steg P.G., Eagle K.A. et al. GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 // J. Am. Med. Assoc. — 2007. — Vol. 297, № 17. — P. 1892-1900.
3. Patel M.R., Dehmer G.J., Hirshfeld J.W. et al. Appropriate use criteria for coronary revascularization focused update // J. Am. Cardiol. Coll. — 2012. — Vol. 59, № 9 — P. 857-881.
4. Tricoci P., Allen J.M., Kramer J.M. et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines // J. Am. Med. Assoc. — 2009. — Vol. 301, № 8. — P. 831-841.
5. Brown M.L., Gersh B.J., Holmes D.R. et al. From randomized trials to registry studies: translating data into clinical information // Nat. Clin. Pract. Cardiovasc. Med. — 2008. — Vol. 5, № 10. — P. 613-620.
6. Agency for healthcare research and quality. Registries for evaluating patient outcomes: a user’s guide: 2nd Edition. — Mar. 3, 2010.
7. Явелов И.С. Лечение острого коронарного синдрома без подъемов сегмента ST в России (по данным регистра острых коронарных синдромов 2000-2001 и 2003 гг.) // Сердце. —2005. — № 4. — C. 210-213.
8. Дупляков Д.В., Хохлунов С.М., Тухбатова А.А. и др. Возможность госпитального регистра ОКСБПST в оценке качества медицинской помощи (сравнение с данными Европейского регистра ACS-II) // Материалы III Съезда кардиологов Приволжского федерального округа. — Самара. — 2010. — C. 163-164.
9. Rumsfeld J.S., Dehmer G.J., Brindis R.G. The National cardiovascular data registry — its role in Benchmarking Gregory J and improving quality // US Cardiology. — 2009. — Vol. 6, № 2. — P. 11-15.
10. Li Y., Zheng Z., Hu S., on behalf of the Chinese CABG Registry Study. The Chinese coronary artery bypass grafting registry study: analysis of the national multicentre database of 9248 patients // Heart. — 2009. — Vol. 95, № 14. — P. 1140-1144.
11. Gliklich R.E., Dreyer N.A., eds. Registries for evaluating patient outcomes: a user’s guide [AHRQ publication No. 07-EHC001-1, April 2007]. Agency for Healthcare Research and Quality. http://effectivehealthcare.ahrq.gov/repFiles /DEcIDEs_ Registries.html.
12. Dreyer N.A., Garner S. Registries for robust evidence // J. Am. Med. Assoc. — 2009. — Vol. 302, № 7. — P. 790-791.
13. Alexander K.P., Chen A.Y., Roe M.T. et al. CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes // J. Am. Med. Assoc. — 2005. — Vol. 294, № 23. — P. 3108-3116.
14. Bravata D.M., McDonald K.M., Gienger A.L. et al. Comparative effectiveness of percutaneous coronary interventions and coronary artery bypass grafting for coronary artery disease // Comparative Effectiveness Rev. — № 9, October 2007. — Agency for Healthcare Research and Quality. — Accessed July 6. — 2009.
15. Dzavik V., Ghali W.A., Norris C. et al. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators // Am. Heart J. — 2001. — Vol. 142, № 1. — P. 119-126.
16. Velazquez E.J., Lee K.L., Deja M.A. et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction // N. Engl. J. Med. — 2011. — Vol. 364, № 17. — P. 1607.
17. Gitt A.K., Bueno H., Danchin N. et al. The role of cardiac registries in evidence-based medicine // Eur. Heart J. — 2010. — Vol. 31, № 5. — P. 520-521.
18. Alpert J.S. Are data from clinical registries of any value? // Eur. Heart J. — 2000. — Vol. 21, № 17. — P. 1399-1401.
19. Alpert J.S. Acute coronary syndromes observed from an international perspective // Eur. Heart J. — 2002. — Vol. 23, № 15. — P. 1139-1140.
20. Brown M.L., Gersh B.J., Holmes D.R., Bailey K.R., Sundt T.M. 3rd. From randomized trials to registry studies: translating data into clinical information // Nat. Clin. Pract. Cardiovasc. Med. — 2008. — Vol. 5, № 10. — P. 613-620.
21. Flynn M.R., Barrett C., Cosio F.G. et al. The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice // Eur. Heart J. — 2005. — Vol. 26, № 3. — P. 308-313.
22. Gitt A.K., Bueno H., Danchin N. et al. The role of cardiac registries in evidence-based Medicine European // Heart J. — 2010. — Vol. 31, № 5. — P. 525-529.
23. Granger Ch.B., Gersh B.J. Clinical trials and registries in cardiovascular disease: competitive or complementary? // Eur. Heart J. — 2010. — Vol. 31, № 5. — P. 520-521.
24. Chatzistamatiou E.I., Moustakas G.N., Rodolakis N.E. et al. Stable coronary artery disease: latest data in the battle between conservative and invasive management // Hellenic J. Cardiol. — 2011. — Vol. 52, № 6. — P. 516-524.
25. Caracciolo E.A., Davis K.B., Sopko G. et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease long-term CASS experience // Circulation. — 1995. — Vol. 91, № 9. — P. 2335-2344.
26. Dzavik V., Ghali W.A., Norris C. et al. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators // Am. Heart J. — 2001. — Vol. 142, № 1. — P. 119-126.
27. Pell J.P., Walsh D., Norrie J. et al. Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period // Heart. — 2001. — Vol. 85, № 6. — P. 662-666.
28. Malenka D.J., Leavitt B.J., Hearne M.J. et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern // N. Engl. Circul. — 2005. — Vol. 112, № 9. — P. I371-I376.
29. Hannan E.L., Racz M.J., Walford G. et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation // N. Engl. J. Med. — 2005. — Vol. 352, № 21. — P. 2174-2183.
30. Peterson E.D., Dai D., DeLong E.R. et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry // J. Am. Coll. Cardiol. — 2010. — Vol. 55, № 18. — P. 1923-1932.
31. Daly C.A., Clemens F., Sendon J.L.L. et al. The initial management of stable angina in Europe, from the Euro Heart Survey // Eur. Heart J. — 2005. — Vol. 26, № 10. — P. 1011-1022.
32. Lenzen M.J., Boersma E., Bertrand M.E. et al. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization // Eur. Heart J. — 2005. — Vol. 26, № 12. — P. 1169-1179.
33. Patel M.R., Dehmer G.J., Hirshfeld J.W. et al. ACCF/ SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness criteria for coronary revascularization // J. Am. Coll. Cardiol. — 2009. — Vol. 53, № 6. — P. 530-553.
34. Wijns W., Kolh Ph., Danchin N. et al. Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) // Eur. Heart J. — 2010. — Vol. 31, № 20. — P. 2501-2555.
35. Hillis L.D., Smith P., Anderson J. et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery // J. Am. Coll. Cardiol. — 2011. — Vol. 58, № 24. — P. 123-210.
36. Явелов И.С., Грацианский Н.А. Российский регистр острых коронарных синдромов: лечение и исходы в стационаре при остром коронарном синдроме без подъемов сегмента ST // Кардиология. — 2003. — № 12. — C. 16-29.
37. Эрлих А.Д. Регистры острых коронарных синдромов — их виды, характеристики и место в клинической практике // Вестн. Рос. акад. мед. наук. — 2012. — № 4. — C. 30-39.
38. American Heart Association. Heart disease and stroke statistics — 2009 update // Circulation. — 2009. — Vol. 119, № 3. — P. e21-e181.
39. Kim D. Medicare payment reform and hospital costs: evidence from the prospective payment system and the treatment of cardiac disease. — November 20, 2011. — JEL Codes: H51, I11, I18, L51.
40. Hilborne L.H., Leape L.L., Bernstein S.J. et al. The appropriateness of use of percutaneous transluminal coronary angioplasty in New York State // J. Am. Med. Assoc. — 1993. — Vol. 269, № 6. — P. 761-765.
41. Ballard D.J. Applying appropriateness methods to address overuse while ensuring the delivery of appropriate care: the example of cardiac revascularization prescriptions for excellence in HEALTH CARE Issue 8 // SPRING — 2010.
42. National Priorities Partnership. National Priorities and Goals: Aligning Our Efforts to Transform America’s Healthcare. Washington, D.C.: // National Quality Forum. — 2008.
43. Hannan E.L., Cozzens K., Samadashvili Z. et al. Appropriateness of coronary revascularization for patients without acute coronary syndromes // J. Am. Coll. Cardiol. — 2012. — Vol. 59, № 21. — P. 1870-1876.
44. Fitch K., LaAzaro P., Aguilar M.D. et al. European criteria for the appropriateness and necessity of coronary revascularization procedures // Eur. J. Cardio-thoracic Surg. — 2000. — Vol. 18, № 4. — P. 380-387.
45. Chan P.S., Patel M.R., Klein L.W. et al. Appropriateness of percutaneous coronary intervention // J. Am. Med. Assoc. — 2011. — Vol. 306, № 1. — P. 53-61.
46. Kimmel K.C., Sensmeier J., Reeves R. Pay for performance: an economic imperative for clinical information systems. Available at: http://www/himss.org/content/files/PayForPerfor-mance. January 25. — 2010.
47. Levine G.N., Bates E.R., Blankenship J.C. et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention // J. Am. Coll. Cardiol. — 2011. — Vol. 58, № 24. — Р. 2550-2583.
48. Davies R.F., Goldberg A.D., Forman S. et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization // Circulation. — 1997. — Vol. 95, № 8. — P. 2037-2043.
49. Shaw L.J., Berman D.S., Maron D.J. et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy // Circulation. — 2008. — Vol. 117, № 10. — P. 1283-1291.
50. De Bruyne B., Pijls N.H.J., Kalesan B. et al. for the FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease // N. Engl. J. Med. — 2012. — Vol. 367, № 11. — P. 991-1001.
Рецензия
Для цитирования:
Панов А.В., Кулешова Э.В. Регистры и их значение в оценке больных ишемической болезнью сердца, подвергающихся операциям реваскуляризации миокарда. Артериальная гипертензия. 2012;18(5):398-405. https://doi.org/10.18705/1607-419X-2012-18-5-398-405
For citation:
Panov A.V., Kuleshova E.V. Registries and their role in management of patients with coronary artery disease undergoing revascularization surgery. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2012;18(5):398-405. (In Russ.) https://doi.org/10.18705/1607-419X-2012-18-5-398-405
Просмотров: 532
Послать статью по эл. почте 